Have Any Questions?



1991    – Started as Intermed Pharma to manufacture of intermediates to APIs.


2001    – Unit-2 was commissioned to manufacture advanced intermediates.


2006    – Commenced manufacturing of Capecitabine (Oncology APIs).


2007    – Commenced manufacturing of First General APIs (Efavirenz).


2009    – Company name changed as Cdymax (India) Pharma Pvt. Ltd.


2011    – New Production Block  (PB-2) commissioned  to manufacture of  Oncology APIs and

…………started manufacturing  from July 2011.


2012    – Company name changed as Acebright (India) Pharma Pvt. Ltd., in April 2012.


2012   – Production Block (PB-1) renovated for manufacturing of General APIs.


2013   – WHO Geneva Approval.